PPCB (Propanc Biopharma) Accounts Payable: $0.97 Mil (As of Mar. 2026)


PPCB Propanc Biopharma Inc PPCB
29 GF Score
Price $1.44
! 2 Warning Signs
View Full Analysis

What is Propanc Biopharma Accounts Payable?

Propanc Biopharma PPCB -4.00% 29 Accounts Payable is $0.97 Mil as of Mar. 2026. GuruFocus rates PPCB with a GF Score™ of 29/100. The stock has 2 warning signs investors should review.

Propanc Biopharma's Accounts Payable for the quarter that ended in Mar. 2026 was $0.97 Mil.

Propanc Biopharma's quarterly Accounts Payable declined from Sep. 2025 ($1.07 Mil) to Dec. 2025 ($0.96 Mil) but then increased from Dec. 2025 ($0.96 Mil) to Mar. 2026 ($0.97 Mil).

Propanc Biopharma's annual Accounts Payable increased from Jun. 2023 ($0.97 Mil) to Jun. 2024 ($1.21 Mil) and increased from Jun. 2024 ($1.21 Mil) to Jun. 2025 ($1.25 Mil).

Propanc Biopharma Accounts Payable Related Terms

Propanc Biopharma Accounts Payable Historical Data

* Premium members only.

The historical data trend for Propanc Biopharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Propanc Biopharma Accounts Payable Chart

Propanc Biopharma Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.00 0.94 0.97 1.21 1.25

Propanc Biopharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.12 1.25 1.07 0.96 0.97
PPCB
29GF Score
Propanc Biopharma Inc PPCB
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Propanc Biopharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.97 Mil mean?
Propanc Biopharma (PPCB) has a Accounts Payable of $0.97 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Propanc Biopharma and its competitors.
Is Propanc Biopharma's Accounts Payable too high?
Propanc Biopharma's current Accounts Payable is $0.97 Mil. Overall, Propanc Biopharma has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Propanc Biopharma's Accounts Payable compare to GRI and BGMS?
Propanc Biopharma's Accounts Payable of $0.97 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Propanc Biopharma and its competitors. Propanc Biopharma's current Accounts Payable is $0.97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Propanc Biopharma stock overvalued right now?
Propanc Biopharma (PPCB) has a current Accounts Payable of $0.97 Mil. The current Accounts Payable is $0.97 Mil. Propanc Biopharma's overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Propanc Biopharma (PPCB), the current Accounts Payable is $0.97 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Propanc Biopharma Business Description

Address 302, 6 Butler Street, Cambwerwell, VIC, AUS, 3124
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
29GF Score

Get the complete analysis for PPCB

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.44
Price